Seeing Is Believing
Currently out of the existing stock ratings of Thomas Smith, 53 are a BUY (74.65%), 18 are a HOLD (25.35%).
Analyst Thomas Smith works at LEERINK with a stock forecast success ratio of 44.87% fulfilled within 114.4 days on average.
Thomas Smith’s has documented 138 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on RAPT, RAPT Therapeutics at 21-Feb-2024.
Analyst best performing recommendations are on AXLA (AXCELLA HEALTH).
The best stock recommendation documented was for AXLA (AXCELLA HEALTH) at 12/15/2022. The price target of $6 was fulfilled within 1 day with a profit of $4.98 (45.36%) receiving and performance score of 453.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1
$-0.02 (-1.96%)
1.5
3 months 9 days ago
5/6 (83.33%)
$-0.02 (-1.96%)
301
Buy
3
$1.98 (194.12%)
3 months 9 days ago
0/2 (0%)
$1.98 (194.12%)
Buy
4 months 8 days ago
1/1 (100%)
$32.69 (83.16%)
358
Buy
9
$7.98 (782.35%)
11 months 15 days ago
2/4 (50%)
$4.84 (116.35%)
178
Buy
7
$5.98 (586.27%)
7
1 years 1 months 19 days ago
1/3 (33.33%)
$0.45 (6.87%)
57
Which stock is Thomas Smith is most bullish on?
Which stock is Thomas Smith is most reserved on?
What Year was the first public recommendation made by Thomas Smith?